During our webinar PPMD President Pat Furlong and Dr. Tim Franson (Chief Medical Officer of Your Encore and former VP of Global Regulatory Affairs and Drug Safety at Eli Lilly) discussed what we can expect out of the upcoming Advisory Committee meetings with the FDA. Not only did Pat and Tim discuss the kinds of recommendations that can come out of these meetings, but they examined how these recommendations potentially affect the FDA's ultimate decision on whether or not to approve potential therapies.
